Annual Current Ratio
10.28
+2.28+28.50%
31 December 2023
Summary:
Enliven Therapeutics annual current ratio is currently 10.28, with the most recent change of +2.28 (+28.50%) on 31 December 2023. During the last 3 years, it has fallen by -78.07 (-88.36%). ELVN annual current ratio is now -88.36% below its all-time high of 88.35, reached on 01 December 2020.ELVN Current Ratio Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Current Ratio
17.44
+3.05+21.20%
30 September 2024
Summary:
Enliven Therapeutics quarterly current ratio is currently 17.44, with the most recent change of +3.05 (+21.20%) on 30 September 2024. Over the past year, it has dropped by -4.80 (-21.58%). ELVN quarterly current ratio is now -43.67% below its all-time high of 30.96, reached on 30 June 2023.ELVN Quarterly Current Ratio Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
ELVN Current Ratio Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +28.5% | -21.6% |
| 3 y3 years | -88.4% | -9.4% |
| 5 y5 years | - | - |
ELVN Current Ratio High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -88.4% | +28.5% | -43.7% | +118.0% |
| 5 y | 5 years | -88.4% | +28.5% | -43.7% | +118.0% |
| alltime | all time | -88.4% | +28.5% | -43.7% | +118.0% |
Enliven Therapeutics Current Ratio History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | 17.44(+21.2%) |
| June 2024 | - | 14.39(+6.8%) |
| Mar 2024 | - | 13.47(+31.0%) |
| Dec 2023 | 10.28 | 10.28(-53.8%) |
| Sept 2023 | - | 22.24(-28.2%) |
| June 2023 | - | 30.96(+13.7%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2023 | - | 27.23(+240.4%) |
| Dec 2022 | 8.00(-58.4%) | 8.00(-24.5%) |
| Sept 2022 | - | 10.59(-45.0%) |
| Dec 2021 | 19.24(-78.2%) | - |
| Dec 2021 | - | 19.24 |
| Dec 2020 | 88.35 | - |
FAQ
- What is Enliven Therapeutics annual current ratio?
- What is the all time high annual current ratio for Enliven Therapeutics?
- What is Enliven Therapeutics annual current ratio year-on-year change?
- What is Enliven Therapeutics quarterly current ratio?
- What is the all time high quarterly current ratio for Enliven Therapeutics?
- What is Enliven Therapeutics quarterly current ratio year-on-year change?
What is Enliven Therapeutics annual current ratio?
The current annual current ratio of ELVN is 10.28
What is the all time high annual current ratio for Enliven Therapeutics?
Enliven Therapeutics all-time high annual current ratio is 88.35
What is Enliven Therapeutics annual current ratio year-on-year change?
Over the past year, ELVN annual current ratio has changed by +2.28 (+28.50%)
What is Enliven Therapeutics quarterly current ratio?
The current quarterly current ratio of ELVN is 17.44
What is the all time high quarterly current ratio for Enliven Therapeutics?
Enliven Therapeutics all-time high quarterly current ratio is 30.96
What is Enliven Therapeutics quarterly current ratio year-on-year change?
Over the past year, ELVN quarterly current ratio has changed by -4.80 (-21.58%)